CSIMarket Company Name, Ticker, Customers, else..


Ars Pharmaceuticals Inc   (NASDAQ: SPRY)
Other Ticker:  
 

Ars Pharmaceuticals Inc

SPRY's Fundamental analysis



Looking into Ars Pharmaceuticals Inc growth rates, revenue grew in III. Quarter 2024 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.73 %

Ars Pharmaceuticals Inc net loss increased from $-15 millions, to $-19 millions in III. Quarter 2024,

• More on SPRY's Growth


Ars Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Ars Pharmaceuticals Inc realized cash reduction of $ -0.22 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 464.57.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.16.


• More on SPRY's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 13.29
 Tangible Book Value (Per Share $) 1.99

Ars Pharmaceuticals Inc
realized net loss in trailing twelve months.

Ars Pharmaceuticals Inc realized cash outflow of $ -0.22per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 464.57.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.16.

Ars Pharmaceuticals Inc Price to Book Ratio is at 5.94 lower than Industry Avg. of 79.2. and higher than S&P 500 Avg. of 0.01

• More on SPRY's Valuation

•  Market Capitalization (Millions $) 1,193
•  Shares Outstanding (Millions) 97
•  Employees -
•  Revenues (TTM) (Millions $) 3
•  Net Income (TTM) (Millions $) -49
•  Cash Flow (TTM) (Millions $) -21
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 13.29
•  Tangible Book Value (Per Share $) 1.99

•  Market Capitalization (Millions $) 1,193
•  Shares Outstanding (Millions) 97
•  Employees -
•  Revenues (TTM) (Millions $) 3
•  Net Income (TTM) (Millions $) -49
•  Cash Flow (TTM) (Millions $) -21
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 12.64
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.09
•  Asset Turnover Ratio (TTM) 0.01
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com